Abstract
Forty-five clinical and 55 environmental strains of Cryptococcus neoformans var. neoformans from São Paulo, Brazil, were tested for their susceptibilities to amphotericin B, fluconazole, itraconazole, and flucytosine by the broth microdilution method according to the National Committee of Clinical Laboratory Standards guidelines. Electrophoretic karyotypes analysis by counter-clamped homogeneous electrophoresis was used to compare their genetic relatedness. Molecular typing revealed three clinical profiles very similar to two environmental profiles and an identical environmental and clinical profile. The results showed that human cryptococcosis can be acquired from environmental strains, which had similar minimum inhibitory concentration values to clinical strains, for antifungal agents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
BP Currie A Casadevall (1994) ArticleTitleEstimation of the prevalence of cryptococcal infection among HIV infected individuals in New York City. Clin Infect Dis 19 1029–1033
Ministério da Saúde. Programa nacional de doenças sexualmente transmissíveis Brasília, Brasil. Boletim Epidemiológico de AIDS 1999; Ano I (01): 44.
R Rozembaum AJR Gonçalves (1994) ArticleTitleClinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis 18 369–380
TG Mitchell JR Perfect (1995) ArticleTitleCryptococosis in the era of AIDS–100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 8 515–548 Occurrence Handle1:STN:280:BymC3MvitFQ%3D Occurrence Handle8665468
A Casadevall JR Perfect (1998) Cryptococcus neoformans A Casadevall JR Perfect (Eds) Ecology of Cryptococcus neoformans ASM Press Washington DC 41–70
MS Lazéra FDA Pires LC Coura MM Nishikawa (1996) ArticleTitleNatural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 34 127–131
SM Levitz (1991) ArticleTitleThe ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 13 1163–1169
BP Currie LF Freundlich A Casadevall (1994) ArticleTitleRestriction fragment length polymorphism analyses of Cryptococcus neoformans strains from environmental (pigeon excreta) and clinical strains in New York City. J Clin Microbiol 32 1188–1192
SP Franzot JS Hamdan BP Currie A Casadevall (1997) ArticleTitleMolecular epidemiology of Cryptococcus neoformans in Brazil and the United States: Evidence for both local genetic differences and a global clonal population structure. J Clin Microbiol 35 2243–2251
Y Yamamoto S Kohno H Koga H Kakeya K Tomono M Kaku T Yamazaki M Arisawa K Hara (1995) ArticleTitleRandom amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki. J Clin Microbiol 33 3328–3332
SH Alves LT Oliveira JM Costa I Lubeck AK Casali MH Vainstein (2001) ArticleTitleIn vitro susceptibility to antifungal agents of clinical and environmental Cryptococcus neoformans isolated in southern of Brazil. Rev Inst Med Trop São Paulo 43 267–270
F Barchiese R Hollis SA Messer G Scalise MG Rinald MA Pfaller (1995) ArticleTitleElectrophoretic and in vitro antifungal susceptibility of Cryptococcus neoformans strains from AIDS patients. Diagn Microbiol Infect Dis 23 99–103
AJ Bava R Negroni (1989) ArticleTitleSusceptibilidade “in vitro” de cepas de Cryptococcus a 5 drogas antifúngicas. Rev Inst Med Trop São Paulo 31 346–350
BM Calvo AL Colombo O Fischiman A Santiago L Thompson M Lazera F Telles K Fukushima K Nishimura R Tanaka M Myiajy ML Moretti-Branchini (2001) ArticleTitleAntifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical strains of Cryptococcus neoformans from Brazil, Chile, and Venezuela. J Clin Microbiol 39 2348–2350
SP Franzot JS Hamdan (1996) ArticleTitleIn vitro susceptibilities of clinical and environmental strains of Cryptococcus neoformans to five antifungal drugs. Antimicrobiol Agent Chemother 40 822–824
RA Fromtling GK Abruzzo A Ruiz (1989) ArticleTitleVirulence and antifungal susceptibility of environmental and clinical strains of Cryptococcus neoformans from Puerto Rico. Mycopathologia 106 163–166
A Li K Nishimura R Tanaka S Wu M Miyaji (1993) ArticleTitleThe isolation of Cryptococcus neoformans from pigeon droppings and naturally and clinically sourced isolates in China. Mycopathologia 124 1–5
Lacaz CS, Porto E, Martins JEC. Técnicas micológicas e imunológicas. In Micologia médica. Fungos, actinomicetos e algas de interesse médico. São Paulo, Brazil: Sarvier, 1991: 545–608.
KJ Kwon-Chung I Polacheck JE Bennett (1982) ArticleTitleImproved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 15 535–537
National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: document M27A. Villanova PA. Documente M27A, 1997.
BC Fries F Chen BP Currie A Casadevall (1996) ArticleTitleKaryotype instability in Cryptococcus neoformans infection. J Clin Microbiol 34 1531–1534
BI Wickes TDE Moore KJ Kwon-Chung (1994) ArticleTitleComparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology 140 543–550
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Delgado, A., Taguchi, H., Mikami, Y. et al. Human cryptococcosis: relationship of environmental and clinical strains of Cryptococcus neoformans var. neoformans from urban and rural areas. Mycopathologia 159, 7–11 (2005). https://doi.org/10.1007/s11046-004-9618-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11046-004-9618-4